1003-3734
2002 Issue 1
..............page:77
Zenapai
miao hong jing
miao hong jing
..............page:99-100
sai jin
yu ji ying ; wu zheng zhong ; he lin
yu ji ying ; wu zheng zhong ; he lin
..............page:98-99
dong gan shu biao pi sheng chang yin zi
liao cai xia ; xia qing lan ; ye wei hong
liao cai xia ; xia qing lan ; ye wei hong
..............page:97-98
Ayzaar
zhao zhi gang ; peng min
zhao zhi gang ; peng min
..............page:95-96
jing di zao suan shuang zuo na zhi guo min xing xiu ke 1 li
yang zhi cai ; zhang mei hua
yang zhi cai ; zhang mei hua
..............page:60-60
8 cases of severe or infrequent adverse drug react ions
zhou ying ; lu yun lan
zhou ying ; lu yun lan
..............page:92-94
Clinical study on the effects of Tangmaikang upo n urinary microalbumin excretive rate in patients with type 2 diabetes mellitu s
chi jia min ; fu ling chen
chi jia min ; fu ling chen
..............page:89-91
..............page:87-89
A Prospective, Randomized, Felodipine Controlled Trial R esearch on Valsartan for the Treatment of Cerebral Infarction
zuo lian qiu ; liu xue wen ; yuan jing ; zheng chun lan ; ma yan hui ; yang li ; zhang jing bo ; hou feng ying
zuo lian qiu ; liu xue wen ; yuan jing ; zheng chun lan ; ma yan hui ; yang li ; zhang jing bo ; hou feng ying
..............page:84-87
The advances in research of the biodegradation and biocompatibility of PLA and PLGA microspheres
zhao feng ; gao yong liang
zhao feng ; gao yong liang
..............page:67-71
Progress in the Research of β-Lactam Antibiotics
zhang zhi ping
zhang zhi ping
..............page:61-67
..............page:55-60
xin yao yao li du li yan jiu de guo ji shen bao yao qiu ren yong yao wu zhu ce ji shu yao qiu guo ji xie diao hui yi (ich-5)
qian zuo li ; deng zhong ping
qian zuo li ; deng zhong ping
..............page:51-55
Classification and Development of TCM Fingerprint
luo guo an ; wang yi ming
luo guo an ; wang yi ming
..............page:46-51
Nanoparticulate systems for drug delivery
ping qi neng
ping qi neng
..............page:42-46
Research Advances in Human Cytochrome P450s and their Application in New Drug Evaluation
ma ; qian zuo li
ma ; qian zuo li
..............page:36-42
..............page:31-36
Application of Biochip Technology in Drug Discovery and Development
deng zuo ; ning zhi qiang ; zhou yu xiang ; cheng jing
deng zuo ; ning zhi qiang ; zhou yu xiang ; cheng jing
..............page:23-31
xin yao yan jiu yu kai fa de jin zhan ( zhai yao )
zhou hai jun
zhou hai jun
..............page:21-23
tan zhong guo dui yao pin de zhi shi chan quan bao hu
zhang qing kui
zhang qing kui
..............page:17-21
..............page:15-17
ru he xie lun wen zuo bao gao
qin bo yi
qin bo yi
..............page:12-14
..............page:4-11
Study of the effects of lumbrokinase on fibrinogen,D -dimmer ＆ platelet aggregation on patients with ischemic cerebral vascular disease
sheng ai zhen ; wang xin de ; xu zhong bao ; long jie ; dai zhi hua ; wu bo xian ; zhu ke ; fang ding hua ; wei dong ning
sheng ai zhen ; wang xin de ; xu zhong bao ; long jie ; dai zhi hua ; wu bo xian ; zhu ke ; fang ding hua ; wei dong ning
..............page:82-84
The test for compatibility of nimodipine and its absor ption on infusion sets
wei zuo ; tan qiang ; li hui
wei zuo ; tan qiang ; li hui
..............page:80-81
Capillary gas chromatographic determination of residua l solvents in chrolobenzylidine
wang zhi qun ; tu jie ; ni kun yi ; hao xiang
wang zhi qun ; tu jie ; ni kun yi ; hao xiang
..............page:78-79
The effects of losartan on the proliferation of vascular smooth muscle cells and expression of apoptosis-related genes
huang shao hua ; liu jian kang ; chen min sheng
huang shao hua ; liu jian kang ; chen min sheng
..............page:74-77
Preventive effect of aminoguanidine monohydrochloride on galactose cataract in rat
song dan qing ; song xu ; cai nian sheng
song dan qing ; song xu ; cai nian sheng
..............page:72-74